Dong Sung Bio Pharm.Co.,Ltd. (002210.KS)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in KRW| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | KRW bn | 88 | 84 | 93 | 89 | 88 | 87 | 82 | - |
| Operating profit | KRW bn | -23 | -8 | ||||||
| Net profit | KRW bn | -14 | -4 | -2 | -2 | -7 | -26 | -12 | - |
| EPS reported | KRW | -1,126 | -293.2 | ||||||
| Operating cashflow per share | KRW | -562.4 | -268.2 | ||||||
| Capex per share | KRW | 56.67 | 9.62 | ||||||
| FCF per share | KRW | -619.1 | -277.9 | ||||||
| Free cash flow | KRW bn | -14 | -26 | ||||||
| Net debt | KRW bn | 60 | 1 | ||||||
| Book value equity | KRW bn | 23 | 87 | ||||||
| Book value per share | KRW | 1,022 | 929.1 | ||||||
| Number of shares | m | 22.87 | 94.16 | ||||||
| DPS (TTM paid) | KRW | 0.00 | 0.00 |
Financial summary
Financials in KRW| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 0.95 | 0.25 | ||||||
| P/S LTM | x | 0.26 | 0.27 | ||||||
| P/FCF LTM | x | -1.57 | -0.85 | ||||||
| EV/EBITDA LTM | x | -3.98 | -12.75 | ||||||
| EV/Sales LTM | x | 0.95 | 0.44 | ||||||
| Earnings Yield LTM | % | -1.16% | -8.59% | ||||||
| FCF Yield | % | -63.63% | -117.60% | ||||||
| Quality | |||||||||
| ROE | % | -110.12% | -18.82% | ||||||
| ROIC | % | -19.94% | -4.19% | ||||||
| Operating margin | % | -26.23% | -10.33% | ||||||
| Gross margin | % | +41.71% | +41.24% | ||||||
| FCF/Sales | % | -16.24% | -31.88% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -1.45% | -7.21% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -0.22 | -0.68 | ||||||
| Net Debt/EBITDA | x | -2.91 | -0.18 | ||||||
| EBIT/Net interest | x | -2.35 | -1.05 | ||||||
| Net debt/market cap | % | +2.88% | +1.11% | ||||||
| Net debt/Equity | x | 2.58 | 0.01 | ||||||
| Gross debt/equity | x | 2.74 | 0.44 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations spanning pharmaceuticals, cosmetics, hair dye manufacturing, and photodynamic therapy. Its extensive product range includes a broad selection of over-the-counter (OTC) medications designed to treat a variety of conditions. These encompass liver ailments, menopausal symptoms, skin disorders, obesity, digestive and gum health issues, and hair loss. The company's OTC offerings also feature remedies for fever, pain, inflammation, respiratory illnesses, scar reduction, and sleep disturbances, along with antiviral, anti-diarrhea, anti-nausea, blood circulation enhancing, antifungal, and antihistamine drugs. Supplementary OTC products include keratin softeners, eye nutrition supplements, and essential vitamins. Furthermore, Dong Sung Bio Pharm produces ethical (prescription-only, or ETC) drugs. These target specific medical areas such as endocrine, gastrointestinal, circulatory, neuropsychological, and oncological conditions. Its ETC portfolio also contains analgesic and anti-inflammatory agents, dermato-urinary treatments, antiviral, antibiotic, antifungal, and antihistamine medications, as well as respiratory drugs, steroids, and ophthalmic drops. Beyond its pharmaceutical lines, the company offers a range of consumer health and personal care items. These include hair coloring products, functional health foods, medical devices, various daily necessities, muscle taping supplies, disinfectants, toothpastes, shampoos for anti-hair loss and hair growth, and sanitary pads. Dong Sung Bio Pharm.Co.,Ltd. was founded in 1957 and maintains its headquarters in Seoul, South Korea.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Dong Sung Bio Pharm.Co.,Ltd. (002210.KS)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations spanning pharmaceuticals, cosmetics, hair dye manufacturing, and photodynamic therapy. Its extensive product range includes a broad selection of over-the-counter (OTC) medications designed to treat a variety of conditions. These encompass liver ailments, menopausal symptoms, skin disorders, obesity, digestive and gum health issues, and hair loss. The company's OTC offerings also feature remedies for fever, pain, inflammation, respiratory illnesses, scar reduction, and sleep disturbances, along with antiviral, anti-diarrhea, anti-nausea, blood circulation enhancing, antifungal, and antihistamine drugs. Supplementary OTC products include keratin softeners, eye nutrition supplements, and essential vitamins. Furthermore, Dong Sung Bio Pharm produces ethical (prescription-only, or ETC) drugs. These target specific medical areas such as endocrine, gastrointestinal, circulatory, neuropsychological, and oncological conditions. Its ETC portfolio also contains analgesic and anti-inflammatory agents, dermato-urinary treatments, antiviral, antibiotic, antifungal, and antihistamine medications, as well as respiratory drugs, steroids, and ophthalmic drops. Beyond its pharmaceutical lines, the company offers a range of consumer health and personal care items. These include hair coloring products, functional health foods, medical devices, various daily necessities, muscle taping supplies, disinfectants, toothpastes, shampoos for anti-hair loss and hair growth, and sanitary pads. Dong Sung Bio Pharm.Co.,Ltd. was founded in 1957 and maintains its headquarters in Seoul, South Korea.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free